Login / Signup

Quantifying trial-by-trial variability during cortico-cortical evoked potential mapping of epileptogenic tissue.

Eli J CornblathAlfredo LucasCaren ArmstrongAdam S GreenblattJoel M SteinPeter N HadarRamya RaghupathiEric MarshBrian LittKathryn A DavisErin C Conrad
Published in: Epilepsia (2023)
These findings suggest that standard approaches for CCEP mapping, which involve computing a trial-averaged response over a .2-1 Hz stimulation train, may be masking inter-trial variability that localizes to epileptogenic tissue. We also found that CCEP N1 amplitudes synchronize with ongoing low-frequency oscillations in the hippocampus. Further targeted experiments are needed to determine whether phase-locked stimulation could have a role in localizing epileptogenic tissue.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • high resolution
  • open label
  • brain injury
  • cancer therapy
  • high speed
  • placebo controlled